EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study

P Corcia, D Erazo, M D M Amador, S Beltran, E Bernard, H Blasco, C Boutoleau-Bretonniere, G Bruneteau, J P Camdessanche, W Camu, J Cassereau, A Choumert iD und 27 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.70302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von P Corcia und 38 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Reference SLA et Autres Maladies du Motoneurone, CHU Tours, Tours, France. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Proteins, Superoxide Dismutase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Biogen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease in which genetics plays a central role for both familial and sporadic ALS cases. Systematic genetic analysis for all ALS patients is recommended at the time of diagnosis, leading to an early proposal of specific genetic therapy. Currently, C9orf72 is considered the most frequently mutated gene in ALS. Patients with a SOD1 pathogenic or probably pathogenic variants (ACMG classification) are eligible for SOD1 antisense oligonucleotide therapy.

Objective

To determine the frequency of SOD1 variants and C9orf72 G4C2 repeats in a French ALS population and to describe genotype–phenotype relationships. Material and Methods One thousand incident ALS patients were enrolled from 22 ALS centers in France and followed up for 12 months. Epidemiological, familial history, neurological data, and genetic status were collected. Main Results C9orf72 G4C2 repeats and SOD1 variants were observed in 7.6% and 1.6%, respectively. Fifty percent of SOD1 patients and 51% of C9orf72 patients had sporadic ALS. Fifteen different SOD1 variants were identified within the five exons and one intron. C9orf72 patients had a significantly younger age at onset and a trend toward a faster progression compared to non‐expanded C9orf72 patients. Moreover, among the non ‐SOD1 non ‐C9orf72 population, patients with at least one C9orf72 copy with two G4C2 repeats had a shorter disease duration.

Conclusion

This study confirms SOD1 variants low frequency in the French population and highlights the more rapid disease progression observed in patients carrying C9orf72 expansions. These findings underscore the importance of systematic genetic screening at diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisProteinsSuperoxide DismutaseHumansC9orf72 ProteinSuperoxide Dismutase-1FranceFemaleMaleMiddle AgedAgedAdultPrevalenceAge of OnsetGenetic Variation

Stichwörter der Autor:innen

ALS‐C9orf72‐SOD1ALS‐familialcorrelationgenotype–phenotypesporadic

Substanzen

C9orf72 ProteinSuperoxide Dismutase-1C9orf72 protein, humanSOD1 protein, humanProteinsSuperoxide Dismutase

Autor:innen und Institutionen

  • Centre de Reference SLA et Autres Maladies du Motoneurone, CHU Tours, Tours, France.
  • Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Tours, France.
  • Euro-NMD European Reference Network, Paris, France.
  • Alliance on Clinical Trials for ALS-MND (ACT4ALS-NMD) Network, Bron, France.
  • Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidémiologie Des Maladies Chroniques en Zone Tropicale, Institut D'epidémiologie et de Neurologie Tropicale, OmegaHealth, Limoges, France.
  • Centre de Reference SLA et Autres Maladies du Motoneurone, CHU Limoges, Limoges, France.

ORCID-Profile: A Choumert, K Mouzat

Förderung

  • Biogen

Zitieren

APA

Corcia, P., Erazo, D., Amador, M. D. M., Beltran, S., Bernard, E., Blasco, H., Boutoleau-Bretonniere, C., Bruneteau, G., Camdessanche, J. P., Camu, W., Cassereau, J., Choumert, A., Codron, P., Cintas, P., De La Cruz, E., Danel, V., Desnuelle, C., Eyraud, N., Esselin, F., …, & Vourc'h, P. (2025). Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study. European Journal of Neurology. https://doi.org/10.1111/ene.70302

Vancouver

Corcia P, Erazo D, Amador MDM, Beltran S, Bernard E, Blasco H, et al. Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study. European Journal of Neurology. 2025. doi:10.1111/ene.70302

BibTeX
@article{Corcia2025,
  author = {Corcia, P and Erazo, D and Amador, M D M and Beltran, S and Bernard, E and Blasco, H and Boutoleau-Bretonniere, C and Bruneteau, G and Camdessanche, J P and Camu, W and Cassereau, J and Choumert, A and Codron, P and Cintas, P and De La Cruz, E and Danel, V and Desnuelle, C and Eyraud, N and Esselin, F and Fauret, A L and Lefilliatre, M and Fleury, M C and Genestet, S and Grapperon, A M and Guy, N and Jacquin-Piques, A and Beauvais, K and Lautrette, G and Le Masson, G and Mathis, S and Piegay, A S and Pittion-Vouyovitch, S and Sauleau, P and Soriani, M H and Vershueren, A and Mouzat, K and Guissart, C and Couratier, P and Vourc'h, P},
  title = {Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70302}
}
Kostenlos starten →